Clinical features of drug-induced Parkinsonism

被引:5
|
作者
Shiraiwa, Nobuko [1 ]
Tamaoka, Akira [2 ]
Ohkoshi, Norio [1 ]
机构
[1] Tsukuba Univ Technol, Dept Hlth Sci, Course Neurol, Tsukuba, Ibaraki, Japan
[2] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Neurol, Tsukuba, Ibaraki, Japan
关键词
Drug-induced Parkinsonism; sulpiride; Parkinson's disease; malignant syndrome; oromandibular dyskinesia;
D O I
10.4081/ni.2018.7877
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Drug-induced Parkinsonism is often reversible after withdrawal of the causative drug. Its clinical course, however, is not well understood, as the majority of cases are caused by drugs prescribed by departments outside of neurology. We reviewed 21 cases of drug-induced parkinsonism for several factors, including age, sex, causative drug and reason for prescription, department by which it was prescribed, and outcome. The age at onset ranged from 40 to 87 years, with an average Hoehn and Yahr Scale score of 4, indicating severe disability. Sulpiride was the most commonly observed causative drug (71.4%). All causative drugs were prescribed in non-neurological departments and over one half were prescribed in non-psychiatric departments; most were prescribed to treat depression or abdominal discomfort. Ten patients (48%) were previously diagnosed with a neuromuscular disease, including cerebrovascular diseases and Parkinson's disease. Recovery was observed in 15 cases (71%) after withdrawal of the causative drug, but lingering symptoms were observed in the remaining cases. It is suggested that physicians should be more cautious of Parkinsonian side effects when prescribing such drugs.
引用
收藏
页码:103 / 106
页数:4
相关论文
共 50 条
  • [21] DRUG-INDUCED PARKINSONISM IN THE ELDERLY
    STEPHEN, PJ
    WILLIAMSON, J
    LANCET, 1984, 2 (8411): : 1082 - 1083
  • [22] Pathology in Drug-Induced Parkinsonism
    Shuaib, Umar A.
    Rajput, Ali H.
    Rajput, Alex H.
    ANNALS OF NEUROLOGY, 2014, 76 : S46 - S46
  • [23] PROLONGED DRUG-INDUCED PARKINSONISM
    KLAWANS, HL
    BERGEN, D
    BRUYN, GW
    CONFINIA NEUROLOGICA, 1973, 35 (06): : 368 - 377
  • [24] Bupropion and drug-induced parkinsonism
    Jerome, L
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2001, 46 (06): : 560 - 561
  • [25] DRUG-INDUCED PARKINSONISM - A REVIEW
    MONTASTRUC, JL
    LLAU, ME
    RASCOL, O
    SENARD, JM
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1994, 8 (04) : 293 - 306
  • [26] PERSISTENT DRUG-INDUCED PARKINSONISM
    ARONSON, TA
    BIOLOGICAL PSYCHIATRY, 1985, 20 (07) : 795 - 798
  • [27] A STUDY OF DRUG-INDUCED PARKINSONISM
    STRATAS, NE
    WALKER, PA
    PHILLIPS, RD
    SANDIFER, MG
    DISEASES OF THE NERVOUS SYSTEM, 1963, 24 (03): : 180 - &
  • [28] REVERSIBILITY OF DRUG-INDUCED PARKINSONISM
    CAHAN, RB
    PARRISH, DD
    AMERICAN JOURNAL OF PSYCHIATRY, 1960, 116 (11): : 1022 - 1023
  • [29] To Be or Not to Bupropion: A Drug-induced Parkinsonism?
    Silva, A.
    Pinto, J.
    Gago, M.
    Rodrigues, M.
    MOVEMENT DISORDERS, 2022, 37 : S251 - S251